BioSpace News Archive

Biotech Bay

McKesson Reaffirms Fiscal 2019 Guidance and Provides Preliminary Guidance for the First Quarter

The company also anticipates Adjusted Earnings per diluted share of approximately $2.85 to $2.95 for the first quarter of Fiscal 2019.

June 28, 2018
·
5 min read
Genetown

Arsanis Provides Update Following Completion of Planned Interim Analysis of Phase 2 Clinical Trial of ASN100

Arsanis, Inc. (NASDAQ:ASNS), today announced the discontinuation of its Phase 2 clinical trial of ASN100.

June 28, 2018
·
5 min read
Business

BrainStorm Strengthens Executive Management Team with the Appointment of Susan Ward, Ph.D. and Joseph Petroziello

Susan Ward, Ph.D. (Pfizer) Appointed Head of Clinical Operations Joe Petroziello (Juno Therapeutics) Appointed VP of Scientific & Corporate Communications

June 28, 2018
·
7 min read
Drug Development

PQ Bypass Reports Positive 12-Month Results for Entirely New Procedure to Treat Extremely Long SFA Lesions in Patients with PAD

DETOUR I Trial Presented during SVS Vascular Annual Meeting 2018 Late Breaking Clinical Trial Session

June 28, 2018
·
4 min read
Drug Development

BioAtla Announces First Patient Treated In Phase1/2 BA3021-001 Clinical Trial For CAB-ROR2-ADC Therapeutic

CAB-ROR2-ADC in clinical testing for treatment of several solid tumor types

June 28, 2018
·
4 min read
Pharm Country

Soligenix, Inc. Prices $8,000,000 Public Offering At The Market

The offering is expected to close on July 2, 2018, subject to customary closing conditions.

June 28, 2018
·
6 min read
FDA

Renovis Surgical Receives FDA Clearance for Tesera Trabecular Technology™ Hyperlordotic ALIF Interbody Spinal Fusion System

Tesera SA is a porous titanium stand-alone anterior lumbar interbody fusion system featuring a four-screw design and a locking cover plate to prevent screw backout.

June 28, 2018
·
1 min read
Business

Walgreens Boots Alliance Reports Fiscal 2018 Third Quarter Results

Sales increased 14.0 percent to $34.3 billion

June 28, 2018
·
35 min read
Business

Be The Match BioTherapies Strengthens Business Development Team With New Hires

Be The Match BioTherapies® today announced the appointment of Mark Flower as Vice President, Business Development and Strategic Partnerships, and Erin Rasch as Senior Director, Sales and New Business Development.

June 28, 2018
·
3 min read
Policy

Lipoprotein(a) Foundation Announces Two ICD-10 Diagnostic Codes for Elevated Lipoprotein(a) Approved by the CDC

New ICD-10 Codes Could Accelerate Access to Simple Blood Test for Elevated Lipoprotein(a) and Help Prevent Cardiovascular Events in People Whose Only Risk Factor is Lipoprotein(a).

June 28, 2018
·
4 min read